Kenneth J. Winters
Publications by Year
Research Areas
Antiplatelet Therapy and Cardiovascular Diseases, Lipoproteins and Cardiovascular Health, Venous Thromboembolism Diagnosis and Management, Acute Myocardial Infarction Research, Atrial Fibrillation Management and Outcomes
Most-Cited Works
- → Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization(2012)865 cited
- → Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel(2007)727 cited
- → A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation(2006)568 cited
- → Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease(2006)536 cited
- → Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease(2007)455 cited
- → Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y 12 Antagonist, With Clopidogrel in Percutaneous Coronary Intervention(2005)380 cited
- → Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)(2006)327 cited
- → Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics Differently(2007)321 cited
- → Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel(2008)315 cited
- → Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease(2009)264 cited